• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • Global Development Briefing

    Rumors circle FCDO's debut, US declines vaccine cooperation, and 'Doing Business' under scrutiny: This week in development

    The new U.K. aid and diplomacy office launches, dozens of countries join a COVID-19 vaccine initiative without the U.S., and the World Bank halts publication of its influential “Doing Business” report.

    By Michael Igoe // 03 September 2020
    Seth Berkley, chief executive of Gavi, the Vaccine Alliance, which co-leads the COVAX initiative. Photo by: Bret Hartman / TED / CC BY-NC

    Rumors swirl around the launch of the new U.K. aid and diplomacy office, dozens of countries join a COVID-19 vaccine initiative without the U.S., and the World Bank halts publication of its influential “Doing Business” report. This week in development:

    The U.K. Foreign, Commonwealth & Development Office officially launched Wednesday, signaling the start of a new chapter for Britain’s global development engagement — and the end of the independent Department for International Development. U.K. aid advocates have closely scrutinized the merger of the country’s diplomatic and development enterprises, and they have learned more in the last week about the staffing, oversight, and funding details of the combined office. Some staffing announcements — such as the decision to retain DFID Chief Economist Rachel Glennerster in the same role at FCDO — have been welcomed by an aid community that remains on edge. But the launch of the new office has also been overshadowed by rumors that the U.K. could abandon its commitment to spending 0.7% of its gross national income on aid, as well as ongoing concerns that aid resources could be diverted to programs that do not meet accepted criteria for foreign assistance spending. On Wednesday, Foreign Secretary Dominic Raab sought to dispel those rumors, calling them “tittle-tattle” and telling politicians that “not an element of it has reflected or characterized the conversations that I’ve had across government.”

    Seventy-six upper-middle-income and high-income countries have joined COVAX, the global COVID-19 vaccine-sharing initiative that aims to ensure equitable access to a drug once it becomes available. The U.S. is not one of them. Seth Berkley, chief executive of Gavi, the Vaccine Alliance, which co-leads the initiative with the World Health Organization and the Coalition for Epidemic Preparedness Innovations, provided an update on its international buy-in and funding in an interview with Reuters on Wednesday. “This is good news. It shows that the COVAX facility is open for business and is attracting the type of interest across the world we had hoped it would,” Berkley said. The initiative aims to ensure that when a COVID-19 vaccine is available, it will be distributed globally to health workers and then to the most vulnerable 20% of participating countries’ populations. Funding from wealthier countries will drive the research, development, and distribution of the vaccine, but the initiative’s supporters point out that it is in every country’s interest to stop the spread of COVID-19 everywhere. “COVAX is the only truly global solution that has the capability to end the acute stage of COVID-19 pandemic,” a Gavi spokesperson wrote in an email to Devex last month. The decision by President Donald Trump’s administration not to participate — largely because WHO is involved — has been criticized as a shortsighted and self-defeating risk, since it could limit U.S. access to a vaccine if one is developed in another country.

    The World Bank is delaying publication of its influential “Doing Business” report, due to concerns that its results may have been manipulated to benefit countries that saw their rankings jump in the high-profile index. The report is meant to compare countries according to how well they support private enterprise, tracking indicators related to regulatory reform, corruption, and reducing red tape. Data for four countries — China, Azerbaijan, the United Arab Emirates, and Saudi Arabia — appeared to be inappropriately altered, The Wall Street Journal reported. In a statement last week, the bank described “irregularities” with “changes to the data in the Doing Business 2018 and Doing Business 2020 reports” and announced that it would immediately conduct a systematic review and assessment of data changes related to the last five “Doing Business” reports, as well as an audit of data collection and safeguarding processes. The report’s methodology has come under scrutiny before, including when former World Bank Chief Economist Paul Romer raised concerns about potential data manipulation, a criticism that led to his departure from the institution in 2018.

    • Trade & Policy
    • Humanitarian Aid
    • Global Health
    • Research
    • World Bank
    • FCDO
    • United Kingdom
    • United States
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Michael Igoe

      Michael Igoe@AlterIgoe

      Michael Igoe is a Senior Reporter with Devex, based in Washington, D.C. He covers U.S. foreign aid, global health, climate change, and development finance. Prior to joining Devex, Michael researched water management and climate change adaptation in post-Soviet Central Asia, where he also wrote for EurasiaNet. Michael earned his bachelor's degree from Bowdoin College, where he majored in Russian, and his master’s degree from the University of Montana, where he studied international conservation and development.

    Search for articles

    Related Stories

    Global HealthSeth Berkley warns of an era of ‘polyepidemics’ as cooperation crumbles

    Seth Berkley warns of an era of ‘polyepidemics’ as cooperation crumbles

    Global HealthRobert F. Kennedy Jr. says the US is cutting funding for Gavi

    Robert F. Kennedy Jr. says the US is cutting funding for Gavi

    The Trump EffectOpinion: 7 questions US legislators should ask about the demise of USAID

    Opinion: 7 questions US legislators should ask about the demise of USAID

    Global DevelopmentHow do we fix aid?

    How do we fix aid?

    Most Read

    • 1
      How low-emissions livestock are transforming dairy farming in Africa
    • 2
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 3
      The UN's changing of the guard
    • 4
      Opinion: India’s bold leadership in turning the tide for TB
    • 5
      USAID's humanitarian bureau is under pressure and overstretched
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement